904 related articles for article (PubMed ID: 26355163)
21. BUBR1 overexpression predicts disease-specific survival after nephroureterectomy in patients with upper tract urothelial carcinoma.
Yamamoto Y; Oga A; Akao J; Misumi T; Fuji N; Kobayashi K; Kawai Y; Inoue R; Hirata H; Matsumoto H; Nagao K; Sakano S; Matsuyama H
Jpn J Clin Oncol; 2016 Aug; 46(8):754-61. PubMed ID: 27174960
[TBL] [Abstract][Full Text] [Related]
22. Patterns of Lymphatic Metastases in Upper Tract Urothelial Carcinoma and Proposed Dissection Templates.
Matin SF; Sfakianos JP; Espiritu PN; Coleman JA; Spiess PE
J Urol; 2015 Dec; 194(6):1567-74. PubMed ID: 26094807
[TBL] [Abstract][Full Text] [Related]
23. Squamous differentiation and prognosis in upper urinary tract urothelial carcinoma.
Makise N; Morikawa T; Kawai T; Nakagawa T; Kume H; Homma Y; Fukayama M
Int J Clin Exp Pathol; 2015; 8(6):7203-9. PubMed ID: 26261615
[TBL] [Abstract][Full Text] [Related]
24. The Conditional Survival with Time of Intravesical Recurrence of Upper Tract Urothelial Carcinoma.
Shigeta K; Kikuchi E; Hagiwara M; Ando T; Mizuno R; Abe T; Mikami S; Miyajima A; Nakagawa K; Oya M
J Urol; 2017 Dec; 198(6):1278-1285. PubMed ID: 28634017
[TBL] [Abstract][Full Text] [Related]
25. Comparison of oncological outcomes after segmental ureterectomy or radical nephroureterectomy in urothelial carcinomas of the upper urinary tract: results from a large French multicentre study.
Colin P; Ouzzane A; Pignot G; Ravier E; Crouzet S; Ariane MM; Audouin M; Neuzillet Y; Albouy B; Hurel S; Saint F; Guillotreau J; Guy L; Bigot P; De La Taille A; Arroua F; Marchand C; Matte A; Fais PO; Rouprêt M;
BJU Int; 2012 Oct; 110(8):1134-41. PubMed ID: 22394612
[TBL] [Abstract][Full Text] [Related]
26. Impact of tumour location versus multifocality in patients with upper tract urothelial carcinoma treated with nephroureterectomy and bladder cuff excision: a homogeneous series without perioperative chemotherapy.
Yafi FA; Novara G; Shariat SF; Gupta A; Matsumoto K; Walton TJ; Fritsche HM; El-Hakim A; Trischler S; Martínez-Salamanca JI; Seitz C; Ficarra V; Zattoni F; Karakiewicz PI; Kassouf W
BJU Int; 2012 Jul; 110(2 Pt 2):E7-13. PubMed ID: 22177329
[TBL] [Abstract][Full Text] [Related]
27. Prognostic role of the preoperative serum albumin : globulin ratio after radical nephroureterectomy for upper tract urothelial carcinoma.
Otsuka M; Kamasako T; Uemura T; Takeshita N; Shinozaki T; Kobayashi M; Komaru A; Fukasawa S
Int J Urol; 2018 Oct; 25(10):871-878. PubMed ID: 30103271
[TBL] [Abstract][Full Text] [Related]
28. A role for preoperative systemic chemotherapy in node-positive upper tract urothelial carcinoma treated with radical nephroureterectomy.
Kitamura H; Igarashi M; Tanaka T; Shindo T; Masumori N; Tamakawa M; Kawaai Y; Tsukamoto T
Jpn J Clin Oncol; 2012 Dec; 42(12):1192-6. PubMed ID: 23077244
[TBL] [Abstract][Full Text] [Related]
29. Effect of Adjuvant Systemic Chemotherapy on Intravesical Recurrence After Radical Nephroureterectomy for Upper Urinary Tract Urothelial Carcinoma.
Yamaguchi N; Morizane S; Yumioka T; Shimizu R; Teraoka S; Iwamoto H; Hikita K; Honda M; Takenaka A
Anticancer Res; 2023 Apr; 43(4):1725-1730. PubMed ID: 36974830
[TBL] [Abstract][Full Text] [Related]
30. Preoperative Pyuria Predicts for Intravesical Recurrence in Patients With Urothelial Carcinoma of the Upper Urinary Tract After Radical Nephroureterectomy Without a History of Bladder Cancer.
Sato G; Yoshida T; Yanishi M; Saito R; Murota T; Kawa G; Kinoshita H; Matsuda T
Clin Genitourin Cancer; 2020 Apr; 18(2):e167-e173. PubMed ID: 31635939
[TBL] [Abstract][Full Text] [Related]
31. Clinical implications of intravesical recurrence after radical nephroureterectomy for upper urinary tract urothelial carcinoma.
Yamashita S; Ito A; Mitsuzuka K; Tochigi T; Namima T; Soma F; Aizawa M; Ioritani N; Kaiho Y; Arai Y
Int J Urol; 2016 May; 23(5):378-84. PubMed ID: 26780531
[TBL] [Abstract][Full Text] [Related]
32. Impact of smoking status on bladder tumor recurrence after radical nephroureterectomy for upper tract urothelial carcinoma.
Hagiwara M; Kikuchi E; Tanaka N; Matsumoto K; Ide H; Miyajima A; Masuda T; Nakamura S; Oya M
J Urol; 2013 Jun; 189(6):2062-8. PubMed ID: 23328579
[TBL] [Abstract][Full Text] [Related]
33. Risk factors for intravesical recurrence after nephroureterectomy in patients with upper urinary tract urothelial carcinoma.
Yamashita R; Watanabe R; Ito I; Shinsaka H; Nakamura M; Matsuzaki M; Niwakawa M
Int Urol Nephrol; 2017 Mar; 49(3):425-430. PubMed ID: 28078533
[TBL] [Abstract][Full Text] [Related]
34. Intravesical recurrence after surgical management of urothelial carcinoma of the upper urinary tract.
Hirano D; Okada Y; Nagane Y; Satoh K; Mochida J; Yamanaka Y; Hirakata H; Yamaguchi K; Kawata N; Takahashi S; Henmi A
Urol Int; 2012; 89(1):71-7. PubMed ID: 22677699
[TBL] [Abstract][Full Text] [Related]
35. Impact of lymphovascular invasion on oncological outcomes in patients with upper tract urothelial carcinoma after radical nephroureterectomy.
Hurel S; Rouprêt M; Ouzzane A; Rozet F; Xylinas E; Zerbib M; Berod AA; Ruffion A; Adam E; Cussenot O; Houlgatte A; Phé V; Nouhaud FX; Bensadoun H; Delage F; Guillotreau J; Guy L; Karsenty G; De La Taille A; Colin P;
BJU Int; 2013 Jun; 111(8):1199-207. PubMed ID: 23650914
[TBL] [Abstract][Full Text] [Related]
36. Laparoscopic versus open nephroureterectomy to treat localized and/or locally advanced upper tract urothelial carcinoma: oncological outcomes from a multicenter study.
Liu JY; Dai YB; Zhou FJ; Long Z; Li YH; Xie D; Liu B; Tang J; Tan J; Yao K; He LY
BMC Surg; 2017 Jan; 17(1):8. PubMed ID: 28095848
[TBL] [Abstract][Full Text] [Related]
37. Site of metastatic recurrence impacts prognosis in patients with high-grade upper tract urothelial carcinoma.
Cheaib JG; Claus LE; Patel HD; Kates MR; Matoso A; Hahn NM; Bivalacqua TJ; Hoffman-Censits JH; Pierorazio PM
Urol Oncol; 2021 Jan; 39(1):74.e9-74.e16. PubMed ID: 33071108
[TBL] [Abstract][Full Text] [Related]
38. Association of perioperative blood transfusion with oncologic outcomes after radical nephroureterectomy for upper tract urothelial carcinoma.
Rieken M; Schubert T; Xylinas E; Kluth L; Rouprêt M; Trinh QD; Lee RK; Al Hussein Al Awamlh B; Fajkovic H; Novara G; Margulis V; Lotan Y; Martinez-Salamanca JI; Matsumoto K; Seitz C; Remzi M; Karakiewicz PI; Scherr DS; Briganti A; Bachmann A; Shariat SF;
Eur J Surg Oncol; 2014 Dec; 40(12):1693-9. PubMed ID: 24780094
[TBL] [Abstract][Full Text] [Related]
39. Association between lymphovascular invasion and oncological outcome in node-negative upper tract urothelial carcinoma with different stage.
Chen CS; Lin CY; Wang CL; Wang SS; Li JR; Yang CK; Cheng CL; Chiu KY; Yang SF
Urol Oncol; 2021 Feb; 39(2):132.e13-132.e26. PubMed ID: 32900630
[TBL] [Abstract][Full Text] [Related]
40. Impact of micropapillary histological variant on survival after radical nephroureterectomy for upper tract urothelial carcinoma.
Masson-Lecomte A; Colin P; Bozzini G; Nison L; de La Taille A; Comperat E; Zerbib M; Rozet F; Cathelineau X; Valeri A; Ruffion A; Guy L; Droupy S; Cussenot O; Rouprêt M
World J Urol; 2014 Apr; 32(2):531-7. PubMed ID: 23907662
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
